Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

sanofi b.v. - sevelamero karbonatas - hyperphosphatemia; renal dialysis - visi kiti gydomieji produktai - sevelamer karbonatas winthrop yra nurodyta kontrolės hyperphosphataemia suaugusiųjų pacientams, kuriems hemodializės ar peritoninės dializės. sevelamer karbonatas winthrop taip pat nurodė, kontrolės hyperphosphataemia suaugusiųjų pacientams, sergantiems lėtine inkstų liga, ne dėl dializės su serumo fosforo > 1. 78 mmol / l. sevelamer karbonatas winthrop turėtų būti naudojami pagal kelis terapinis požiūris, kuris galėtų būti kalcio papildas, 1,25-dihidroksi vitaminas d3 ar vienas iš jo analogų kontroliuoti plėtros inkstų, kaulų ligos.

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

rowa pharmaceuticals ltd. - karbenoksolonas - gelis - 20 mg/g - other agents for local oral treatment

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

boiron - abies nigra 4 ch/carbo vegetabilis 4 ch/nux vomica 4 ch/robinia pseudo-acacia 4 ch - tabletės - 75 mg/75 mg/75 mg/75 mg

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

biologische heilmittel heel gmbh - argentum nitricum d6/acidum arsenicosum d6/pulsatilla pratensis d4/strychnos nux-vomica d4/carbo vegetabilis d6/stibium sulfuratum nigrum d6 - tabletės - 30 mg/30 mg/60 mg/60 mg/60 mg/60 mg

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

biologische heilmittel heel gmbh - leptandra d2/quassia amara d3/podophyllum peltatum d3/arsenicum album d4/carbo vegetabilis d10/niccolum metallicum d10/phosphorus d6 - geriamieji lašai (tirpalas) - 1 g/1 g/1 g/1 g/1 g/1 g/1 g/100 mg

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

sandoz d.d. - sevelameras - plėvele dengtos tabletės - 800 mg - sevelamer

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

biologische heilmittel heel gmbh - calcium carbonicum hahnemanni d8/solanum dulcamara d6/chamomilla recutita d4/carbo vegetabilis d12 - tabletės - 180 mg/30 mg/30 mg/60 mg

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

advicenne s.a. - potassium citrate monohydrated, potassium hydrogen carbonate - acidosis, renal tubular - mineral supplements - sibnayal is indicated for the treatment of distal renal tubular acidosis (drta) in adults, adolescents and children aged one year and older.

Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

celltrion healthcare hungary kft. - bevacizumabas - colorectal neoplasms; breast neoplasms; ovarian neoplasms; fallopian tube neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antinavikiniai vaistai - vegzelma in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. vegzelma in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. daugiau informacijos apie žmogaus epidermio augimo faktoriaus receptorių 2 (her2) būklę rasite 5 skyriuje. vegzelma in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with vegzelma in combination with capecitabine. daugiau informacijos apie her2 statusą rasite 5 skyriuje. vegzelma, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer (nsclc) other than predominantly squamous cell histology. vegzelma, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent nsclc with epidermal growth factor receptor (egfr) activating mutations (see section 5. vegzelma, in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. vegzelma, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer (see section 5. vegzelma, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vascular endothelial growth factor (vegf) inhibitors or vegf receptor–targeted agents. vegzelma in combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor–targeted agents (see section 5. vegzelma, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix (see section 5.

Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

egis pharmaceuticals plc - glicerolio trinitratas - poliežuvinis purškalas - 400 µg/išpurškime; 2,6 mg - glyceryl trinitrate